Drug discovery from natural sources

被引:445
作者
Chin, Young-Won
Balunas, Marcy J.
Chai, Hee Byung
Kinghorn, A. Douglas [1 ]
机构
[1] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA
[2] Univ Illinois, Coll Pharm, Program Collaborat Res Pharmaceut Sci, Chicago, IL 60612 USA
[3] Univ Illinois, Coll Pharm, Dept Med Chem, Chicago, IL 60612 USA
[4] Univ Illinois, Coll Pharm, Dept Pharmacognosy, Chicago, IL 60612 USA
关键词
natural products; drug discovery; terrestrial plants; terrestrial microorganisms; marine organisms; terrestrial vertebrates; terrestrial invertebrates; chemical diversity;
D O I
10.1007/BF02854894
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Organic compounds from terrestrial and marine organisms have extensive past and present use in the treatment of many diseases and serve as compounds of interest both in their natural form and as templates for synthetic modification. Over 20 new drugs launched on the market between 2000 and 2005, originating from terrestrial plants, terrestrial microorganisms, marine organisms, and terrestrial vertebrates and invertebrates, are described. These approved substances, representative of very wide chemical diversity, together with several other natural products or their analogs undergoing clinical trials, continue to demonstrate the importance of compounds from natural sources in modern drug discovery efforts.
引用
收藏
页码:E239 / E253
页数:15
相关论文
共 128 条
  • [1] Histone deacetylase inhibitors: From chromatin remodeling to experimental cancer therapeutics
    Arts, J
    de Schepper, S
    Van Emelen, K
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (22) : 2343 - 2350
  • [2] Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824
    Atadja, P
    Gao, L
    Kwon, P
    Trogani, N
    Walker, H
    Hsu, M
    Yeleswarapu, L
    Chandramouli, N
    Perez, L
    Versace, R
    Wu, A
    Sambucetti, L
    Lassota, P
    Cohen, D
    Bair, K
    Wood, A
    Remiszewski, S
    [J]. CANCER RESEARCH, 2004, 64 (02) : 689 - 695
  • [3] Drug discovery from medicinal plants
    Balunas, MJ
    Kinghorn, AD
    [J]. LIFE SCIENCES, 2005, 78 (05) : 431 - 441
  • [4] Mycophenolate mofetil - A review of its use in the management of solid organ transplantation
    Bardsley-Elliot, A
    Noble, S
    Foster, RH
    [J]. BIODRUGS, 1999, 12 (05) : 363 - 410
  • [5] A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis
    Bernier, SG
    Lazarus, DD
    Clark, E
    Doyle, B
    Labenski, MT
    Thompson, CD
    Westlin, WF
    Hannig, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (29) : 10768 - 10773
  • [6] Bisht KS, 2003, CANCER RES, V63, P8984
  • [7] Brostallicin: a new concept in minor groove DNA binder development
    Broggini, M
    Marchini, S
    Fontana, E
    Moneta, D
    Fowst, C
    Geroni, C
    [J]. ANTI-CANCER DRUGS, 2004, 15 (01) : 1 - 6
  • [8] The role of natural product chemistry in drug discovery
    Butler, MS
    [J]. JOURNAL OF NATURAL PRODUCTS, 2004, 67 (12): : 2141 - 2153
  • [9] Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m
  • [10] Capon RJ, 2001, EUR J ORG CHEM, V2001, P633